Westenberg Ritsaart F, van Hooven Daphne, Schep Niels W L, Coert J Henk, Eberlin Kyle R, Chen Neal C
Massachusetts General Hospital, Boston, USA.
Maasstad Hospital, Rotterdam, The Netherlands.
Hand (N Y). 2025 Mar 29:15589447251325827. doi: 10.1177/15589447251325827.
There are no large studies describing patient-reported outcomes after ulnar tunnel release (UTR). The aims of this study are to describe the causes of ulnar tunnel syndrome (UTS), the incidence of UTR, and identify factors associated with long-term patient-reported outcomes after UTR.
We reviewed the medical charts of 76 adult patients who had an UTR for UTS at 1 of 5 academic medical centers between January 1, 2003 and January 1, 2017. Of these patients, 30 completed a follow-up questionnaire including the PROMIS Upper Extremity (PROMIS-UE), Numerical Rating Scale for Pain Intensity (NRS Pain), the Global Rating Scale of Change, and a custom questionnaire about satisfaction and current UTS-specific symptoms.
Approximately 3% of the patients who underwent a decompression surgery of the ulnar nerve at one of our centers between 2003 and 2017 had a UTR. The most frequent described cause of compression was ganglion cyst (16%). The 30 patients who completed the follow-up survey had a mean ± SD PROMIS-UE score of 46.0 ± 12 and a median (interquartile range) NRS Pain score of 0.5 (0-4). Twenty-five patients (83%) described themselves improved compared to before UTR. Bivariate analysis showed that patients who had a preoperative electromyography and nerve conduction velocity study (EMG/NCV) positive for UTS had a higher mean ± SD PROMIS-UE score compared to patients who had a negative EMG/NCV for UTS, respectively 48 ± 12 versus 37 ± 7.6, = .04.
Diagnosis of UTS is challenging and made with substantial variation among surgeons. We observed that most patients improve after UTR, but patients with a negative EMG/NCV have a lower PROMIS Upper Extremity score at long-term follow-up.
目前尚无大型研究描述尺神经沟松解术(UTR)后患者报告的结局。本研究的目的是描述尺神经沟综合征(UTS)的病因、UTR的发生率,并确定与UTR后患者长期报告结局相关的因素。
我们回顾了2003年1月1日至2017年1月1日期间在5家学术医疗中心之一接受UTR治疗UTS的76例成年患者的病历。其中,30例患者完成了一份随访问卷,包括患者报告结局测量信息系统上肢量表(PROMIS-UE)、疼痛强度数字评定量表(NRS疼痛)、总体变化评定量表,以及一份关于满意度和当前UTS特异性症状的定制问卷。
2003年至2017年期间在我们中心之一接受尺神经减压手术的患者中,约3%进行了UTR。最常见的压迫原因是腱鞘囊肿(16%)。完成随访调查的30例患者的PROMIS-UE评分平均±标准差为46.0±12,NRS疼痛评分中位数(四分位间距)为0.5(0-4)。25例患者(83%)表示与UTR前相比有所改善。双变量分析显示,术前肌电图和神经传导速度检查(EMG/NCV)结果为UTS阳性的患者,其PROMIS-UE评分平均±标准差高于EMG/NCV结果为UTS阴性的患者,分别为48±12和37±7.6,P = 0.04。
UTS的诊断具有挑战性,不同外科医生的诊断存在很大差异。我们观察到,大多数患者在UTR后有所改善,但EMG/NCV结果为阴性的患者在长期随访中的PROMIS上肢评分较低。